XML 63 R50.htm IDEA: XBRL DOCUMENT
v3.23.2

Description of Business - Additional Information (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 12 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 01, 2021 | Aug. 31, 2021 | Sep. 30, 2019 | Dec. 31, 2022 | Dec. 31, 2021 | Oct. 31, 2022 | Oct. 14, 2022 | Aug. 31, 2022 | Apr. 19, 2022 | Jan. 27, 2022 | Jul. 31, 2021
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investments in other entities – equity method |  |  |  | $ 40,299 | $ 41,715 |  |  |  |  |  |
Access Primary Care Medical Group |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired |  |  |  |  |  |  |  |  |  |  | 80.00%
Apollo-Sun Labs Management, LLC |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired | 49.00% |  |  |  |  |  |  |  |  |  |
Business combination, equity interest purchase obligation, period to purchase |  | 3 years |  |  |  |  |  |  |  |  |
Consideration transferred | $ 4,000 |  |  |  |  |  |  |  |  |  |
Business combination, equity interest purchase obligation, noncurrent |  |  |  | 5,800 |  |  |  |  |  |  |
Orma Health, Inc., and Provider Growth Solutions LLC |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired |  |  |  |  |  |  |  |  |  | 100.00% |
Jade Health Care Medical Group, Inc. |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired |  |  |  |  |  |  |  |  | 100.00% |  |
Valley Oaks Medical Group |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired |  |  |  |  |  |  | 100.00% |  |  |  |
AAMG |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Interest acquired |  |  |  |  |  | 100.00% |  |  |  |  |
DMG |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investments in other entities – equity method |  |  |  | $ 8,500 |  |  |  |  |  |  |
Affiliated Entity | AP-AMH |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Amount of loan |  |  | $ 545,000 |  |  |  |  |  |  |  |
Term of receivable |  |  | 10 years |  |  |  |  |  |  |  |
Stated rate of note of loan receivable |  |  | 10.00% |  |  |  |  |  |  |  |
Interest rate in the event of default |  |  | 10.75% |  |  |  |  |  |  |  |
Affiliated Entity | APC |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Amount of loan |  |  | $ 300,000 |  |  |  |  |  |  |  |
Number of shares purchased by related party (in shares) |  |  | 15,015,015 |  |  |  |  |  |  |  |
APC | ApolloMed |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment, ownership interest |  |  |  | 18.12% | 19.68% |  |  |  |  |  |
APC | Concourse Diagnostic Surgery Center, LLC |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment, ownership interest |  |  |  | 44.00% |  |  |  |  |  |  |
APC | Affiliated Entity |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Noncontrolling interest, shares distributed |  |  |  |  | 1,000,000 |  |  |  |  |  |
APC | Affiliated Entity | AP-AMH |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Distributions of preferred returns |  |  |  | $ 58,300 | $ 57,900 |  |  |  |  |  |
APC | Affiliated Entity | AP-AMH | Series A Preferred Stock |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of shares purchased by related party (in shares) |  |  | 1,000,000 |  |  |  |  |  |  |  |
Tag-8 Medical Investment Group, LLC — related party |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investments in other entities – equity method |  |  |  |  |  |  |  | $ 4,100 |  |  |
Asset acquisition, percentage of shares acquired |  |  |  | 50.00% |  |  |  |  |  |  |
Asset acquisition, percentage of shares acquired, net |  |  |  |  |  |  |  | 100.00% |  |  |
Tag-6 Medical Investment Group, LLC — related party |  |  |  |  |  |  |  |  |  |  |
Description Of Business [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investments in other entities – equity method |  |  |  |  |  |  |  | $ 4,900 |  |  |
Asset acquisition, percentage of shares acquired |  |  |  |  |  |  |  | 50.00% |  |  |
Asset acquisition, percentage of shares acquired, net |  |  |  |  |  |  |  | 100.00% |  |  |

X
- Definition Asset Acquisition, Percentage Of Shares Acquired + References No definition available. + Details
Name: | ameh_AssetAcquisitionPercentageOfSharesAcquired
Namespace Prefix: | ameh_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Asset Acquisition, Percentage Of Shares Acquired, Net + References No definition available. + Details
Name: | ameh_AssetAcquisitionPercentageOfSharesAcquiredNet
Namespace Prefix: | ameh_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Equity Interest Purchase Obligation, Noncurrent + References No definition available. + Details
Name: | ameh_BusinessCombinationEquityInterestPurchaseObligationNoncurrent
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Equity Interest Purchase Obligation, Period to Purchase + References No definition available. + Details
Name: | ameh_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase
Namespace Prefix: | ameh_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ameh_DescriptionOfBusinessLineItems
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Finance Receivable, Modifications, Subsequent Default, Interest Rate + References No definition available. + Details
Name: | ameh_FinanceReceivableModificationsSubsequentDefaultInterestRate
Namespace Prefix: | ameh_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Finance Receivable, Stated Interest Rate + References No definition available. + Details
Name: | ameh_FinanceReceivableStatedInterestRate
Namespace Prefix: | ameh_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Finance Receivable, Term Of Receivable + References No definition available. + Details
Name: | ameh_FinanceReceivableTermOfReceivable
Namespace Prefix: | ameh_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Noncontrolling Interest, Shares Distributed + References No definition available. + Details
Name: | ameh_NoncontrollingInterestSharesDistributed
Namespace Prefix: | ameh_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 + Details
Name: | us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 50 -Paragraph 5 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522 + Details
Name: | us-gaap_NotesReceivableNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_AccessPrimaryCareMedicalGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_ApolloSunLabsManagementLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_OrmaHealthIncAndProviderGrowthSolutionsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_JadeHealthCareMedicalGroupIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_ValleyOaksMedicalGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ameh_AAMGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_DmgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ameh_APAMHMedicalCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ameh_AlliedPacificOfCaliforniaIPAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ameh_AlliedPacificOfCaliforniaIPAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_ApolloMedicalHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_ConcourseDiagnosticSurgeryCenterLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ameh_Tag8MedicalInvestmentGroupLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ameh_Tag6MedicalInvestmentGroupLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |